Table 2

Correlation of immunohistochemical staining results with histological diagnosis of thyroid lesions

Markers

Benign (98)

Malignant

(54)

Non-Neoplastic HN

52 (%)

Neoplastic

FA/HA

46 (%)

Total

98 (%)

FC

22

PTC

20

FVPC

12

Total

54 (%)


Gal-3

8 (15.3%)

19 (41.3%)

27(27.5%)

18

(81.8%)

18

(90%)

10

(83.3%)

46

(85.1%)

RET

9 (17.3%)

21 (45.6%)

30(30.6%)

16

(72.7%)

18

(90%)

11

(91.7%)

45

(83.3%)

HBME-1

9 (17.3%)

26 (56.5%)

35(35.7%)

18

(81.8%)

18

(90%)

11

(91.7%)

47

(87%)

CK-19

8(15.3%)

23 (50%)

31(31.6%)

19

(86.3%)

17

(85%)

10

(83.3%)

47

(85.1%)


HN: hyperplastic/adenomatoid nodule; FA: Follicular adenoma; HA: Hurthle cell adenoma; FC: Follicular carcinoma; PTC: Papillary thyroid carcinoma; FVPC: Follicular variant of papillary carcinoma

Saleh et al. Diagnostic Pathology 2010 5:9   doi:10.1186/1746-1596-5-9

Open Data